Acknowledgement
본 연구는 2024년도 원광대학교 교비지원에 의해 수행되었습니다
References
- Yuan H-j, Xue Y-t. To Explore the Key Active Compounds and Therapeutic Mechanism of Guizhi Gancao Decoction in Coronary Heart Disease by Network Pharmacology and Molecular Docking. Evid Based Complement Alternat Med. 2022;2022. https://doi.org/10.1155/2022/2566407
- Lazzara F, Conti F, Giuffrida E, Eandi CM, Drago F, Platania CBM, et al. Integrating network pharmacology: The next-generation approach in ocular drug discovery. Curr Opin Pharmacol. 2024;74:102425. https://doi.org/10.1016/j.coph.2023.102425
- Kim H-M, Ko D-G, Park SD. The initial for herbalomics; using "in silico" experiment. Herbal Formula Science. 2022;30(3):205-10. https://doi. org/10.14374/HFS.2022.30.3.205
- Park Y-B, Rhee CK, Yoon HK, Oh Y-M, Lim SY, Lee JH, et al. Revised (2018) COPD clinical practice guideline of the Korean Academy of Tuberculosis and Respiratory Disease: a summary. Tuberc Respir Dis. 2018;81(4):261. https://doi.org/10.4046/trd.2018. 0029
- Ha R, Kim D, Choi J, Jung-Choi K. A national pilot program for chronic diseases and health inequalities in South Korea. BMC public health. 2021;21(1): 1142. https://doi.org/10.1186/s12889-021-11208-7
- Kim I-A, Park Y-B, Yoo K-H. Pharmacotherapy for chronic obstructive pulmonary disease. J Korean Med Assoc. 2018;61:545-51. https://doi.org/ https://doi.org/10.5124/jkma.2018.61.9.545
- Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, Buist AS, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1: the Lung Health Study. JAMA. 1994;272(19):1497-505. https://dx.doi.org/10.5124/jkma.2018.61.9.545
- Nici L, Mammen MJ, Charbek E, Alexander PE, Au DH, Boyd CM, et al. Pharmacologic management of chronic obstructive pulmonary disease. An official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2020;201(9):e56-e69. https://doi.org/10.1164/rccm.202003-0625ST
- Department of Pulmonary Internal Medicine UoKM. Oriental Medicine Pulmonary Internal Medicine. Seoul: Gukjin.
- Lee E-S, Han J-m, Kim M-H, Namgung U, Yeo Y, Park Y-C, et al. Effects of inhalable microparticles of on chronic obstructive pulmonary disease in a mouse model. J Korean Med. 2013;34(3):54-68. https://doi.org/doi.org/10.13048/jkm.13012
- Lee J-G, Yang S-Y, Kim M-H, NamGung U, Park Y-C. Protective effects of Socheongryongtang on elastase-induced lung injury. J Korean Med. 2011;32(4):83-99.
- Kim Y, Yang S-Y, Kim M-H, NamGung U, Park Y-C. Effects of Saengmaekcheongpye-eum on LPS-induced COPD model. J Int Korean Med. 2011;32(2):217-31.
- Han J-M, Yang W-K, Kim S-H, Park Y-C. Effects of Sagan-tang and individual herbs on COPD mice model. Herbal Formula Science. 2015;23(2):171-87. https://doi.org/10.14374/HFS.2015.23.2.171
- Park J-j, Yang W-k, Lyu YR, Kim S-h, Park YC. Inhibitory effects of SGX01 on lung injury of COPD mice model. J Int Korean Med. 2019;40(4):567-81. https://dx.doi.org/10.22246/jikm.2019.40.4.567
- Lee H, Kim Y, Kim HJ, Park S, Jang YP, Jung S, et al. Herbal formula, PM014, attenuates lung inflammation in a murine model of chronic obstructive pulmonary disease. Evid Based Complement Alternat Med. 2012;2012. https://doi.org/
- Kim TH, Yang WK, Lee SW, Kim SH, Lyu YR, Park YC, et al. Inhibitory Effects of GGX on Lung Injury of Chronic Obstructive Lung Disease (COPD) Mice Model. J Korean Med. 2021;42(3):56-71. https://doi.org/10.1155/2012/769830
- Heo J. Donguibogam - Various diseases: Hanbulhagyesa; 2014.
- Lee JW, Baek KM, Chang WS. Single-Dose Oral Toxicity Test of Woohwangchungshim-won in Mice. J Physiol & Pathol Korean Med. 2014;28(2):186-94. https://doi.org/10.15188/kjopp.2014.04.28.2.186
- Kwon D-Y, Oh M-S, Bu Y-m, Seo B-I, Choi H-Y. Herbology. Seoul: Younglimsa; 2004.
- Quan Y, Li L, Yin Z, Chen S, Yi J, Lang J, et al. Bulbus Fritillariae Cirrhosae as a respiratory medicine: is there a potential drug in the treatment of COVID-19? Front Pharmacol. 2022;12:784335. https://doi.org/10.3389/fphar.2021.784335
- Park M, Kang Y. Anti-oxidant and anti-inflammatory activities of various organ extracts from Trichosanthes kirilowii Maxim. Korean J Pharmacogn. 2016;47(4):327-32.
- Zhoh CK, Uhm TY, Kim JC. Antioxidantive effectiveness of Trichosanthes kirilowii Maximowicz extracts. Appl Chem Eng. 2007;18(6):625-9.
- Hikichi M, Mizumura K, Maruoka S, Gon Y. Pathogenesis of chronic obstructive pulmonary disease (COPD) induced by cigarette smoke. J Thorac Dis. 2019;11(Suppl 17):S2129. https://doi.org/10.21037/jtd.2019.10.43
- Yoo C-G. Pathogenesis and pathophysiology of COPD. Korean J Intern Med. 2009;77(4):383-400. https://doi.org/
- Chung K. Cytokines in chronic obstructive pulmonary disease. Eur Respir J. 2001;18(34 suppl):50s-9s. https://doi.org/10.1183/09031936.01.00229701
- Bozinovski S, Vlahos R, Hansen M, Liu K, Anderson GP. Akt in the pathogenesis of COPD. Int J Chron Obstruct Pulmon Dis. 2006;1(1):31-8. https://doi.org/10.2147/copd.2006.1.1.31
- Geraghty P, Wyman AE, Garcia-Arcos I, Dabo AJ, Gadhvi S, Foronjy R. STAT3 modulates cigarette smoke-induced inflammation and protease expression. Front Physiol. 2013;4:267. https://doi.org/10.3389/fphys.2013.00267
- Lebedeva ES, Kuzubova NN, Titova ON, Surkova EA. Effect of cyclooxygenase-2 inhibition on lung inflammation and hypoxia-inducible factor-1 signalling in COPD model. Eur Respiratory Soc. 2017. https://doi.org/10.1183/1393003.congress-2017.PA3926
- Vallath S, Hynds RE, Succony L, Janes SM, Giangreco A. Targeting EGFR signalling in chronic lung disease: therapeutic challenges and opportunities. Eur Respir J. 2014;44(2):513-22. https://doi.org/10.1183/09031936.00146413
- Pandey KC, De S, Mishra PK. Role of proteases in chronic obstructive pulmonary disease. Front Pharmacol. 2017;8:276068. https://doi.org/10.3389/fphar.2017.00512
- Lomas DA. Does protease-antiprotease imbalance explain chronic obstructive pulmonary disease? Ann Am Thorac Soc. 2016;13(Supplement 2):S130-S7. https://doi.org/10.1513/AnnalsATS.201504-196KV
- Zhou X-M, Hou G, Gu D-X, Wang Q-Y, Zhao L. Peroxisome proliferator-activated receptor-γ in induced sputum is correlated with MMP-9/ TIMP-1 imbalance and formation of emphysema in COPD patients. J Thorac Dis. 2017;9(10):3703. https://doi.org/10.21037/jtd.2017.09.10
- Liu J, Liu M, Feng J, Zhu H, Wu J, Zhang H, et al. Alpha-ketoglutarate ameliorates abdominal aortic aneurysm via inhibiting PXDN/HOCL/ERK signaling pathways. J Transl Med. 2022;20(1):461. https://doi.org/10.1186/s12967-022-03659-2
- Morrison D, Rahman I, Lannan S, MacNEE W. Epithelial permeability, inflammation, and oxidant stress in the air spaces of smokers. Am J Respir Crit Care Med. 1999;159(2):473-9. https://doi.org/10.1164/ajrccm.159.2.9804080
- Reddy AT, Lakshmi SP, Banno A, Reddy RC. Role of GPx3 in PPARγ-induced protection against COPD-associated oxidative stress. Free Radic Biol Med. 2018;126:350-7. https://doi.org/10.1016/j.freeradbiomed.2018.08.014
- Li C, Liu Z, Xu Q, Peng H, Cao J, Zhou H, et al. PXDN reduces autophagic flux in insulin-resistant cardiomyocytes via modulating FoxO1. Cell Death Dis. 2021;12(5):418. https://doi.org/10.1038/s41419-021-03699-4
- Demedts IK, Demoor T, Bracke KR, Joos GF, Brusselle GG. Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema. Respir Res. 2006;7:1-10. https://doi.org/10.1186/1465-9921-7-53
- Jan R. Understanding apoptosis and apoptotic pathways targeted cancer therapeutics. Adv Pharm Bull. 2019;9(2):205. https://doi.org/10.15171/apb.2019.024
- Zeng H, Kong X, Peng H, Chen Y, Cai S, Luo H, et al. Apoptosis and Bcl-2 family proteins, taken to chronic obstructive pulmonary disease. Eur Rev Med Pharmacol Sci. 2012;16(6):711-27.
- Zhou B-x, Li J, Liang X-l, Pan X-p, Hao Y-b, Xie P-f, et al. β-sitosterol ameliorates influenza A virus-induced proinflammatory response and acute lung injury in mice by disrupting the cross-talk between RIG-I and IFN/STAT signaling. Acta Pharmacol Sin. 2020;41(9):1178-96. https://doi.org/10.1038/s41401-020-0403-9
- Wang R, Zeng M, Zhang B, Zhang Q, Jia J, Cao B, et al. β-Sitosterol inhibits ovalbumin-induced asthma-related inflammation by regulating dendritic cells. Immunopharmacol Immunotoxicol. 2022;44(6):1013-21. https://doi.org/10.1080/08923973.2022.2102990
- Liu Y, Kong H, Cai H, Chen G, Chen H, Ruan W. Progression of the PI3K/Akt signaling pathway in chronic obstructive pulmonary disease. Front Pharmacol. 2023;14:1238782. https://doi.org/10.3389/fphar.2023.1238782